The largest database of trusted experimental protocols

Latrunculin b

Manufactured by Bio-Techne
Sourced in United Kingdom, United States

Latrunculin B is a naturally occurring macrolide compound that acts as a potent inhibitor of actin polymerization. It binds to actin monomers, preventing their assembly into filaments. This disruption of the actin cytoskeleton can be useful for various cell biology and biochemical applications.

Automatically generated - may contain errors

4 protocols using latrunculin b

1

Preparation of Pharmacological Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stock concentrations of Azithromycin (20 μg/μL, AK-Scientific), CytD (2 mg/mL, Sigma Aldrich), Latrunculin B (2.5 mM, Tocris), Jasplakinolide (1 mM, Sigma Aldrich), and ML10 (10 mM, Lifearc) were made up in DMSO (Sigma Aldrich). Chloroquine (10 mM, Sigma Aldrich) and Heparin (100 mg/mL, Sigma Aldrich) were dissolved in H2O and RPMI, respectively. MMV291, S-MMV291, R-MMV291, S-W936, R-W936, S-W414, S-W415, and S-W827 (Walter and Eliza Hall Institute) were dissolved in DMSO to a 10-mM stock solution.
+ Open protocol
+ Expand
2

Quantifying NP Subcellular Localization in HT1080 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To quantify
subcellular localization of NPs in HT1080 cells, Rab7a-RFP and Lamp1-RFP
fusion constructs were expressed using a commercial baculovirus platform
(CellLight BacMam 2.0, Invitrogen), following manufacturing guidelines.
Pharmacological modulation of NP uptake was performed using the following:
staurosporine (1 μM; LC laboratories), latrunculin B (1 μM;
Tocris), cytochalasin D (1 μM; Sigma), chloroquine (50 μM;
Sigma), and ethylisopropyl amiloride EIPA (100 μM; Tocris).
Cells were rinsed in fresh media immediately prior to imaging; only
adherent cells were quantified. chloroquine dose–response measurements
were normalized to the C16proDOX control (rather than the
chloroquine-free control), in order to compare relative effects on
the potency of Pd-mediated C16proDOX activation itself.
50 μM chloroquine alone caused a 15–30% decrease in cell
viability.
+ Open protocol
+ Expand
3

HSC Cell Culture and Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
HSC cells were seeded at 2 × 104 cells/cm2 atop premade ECM hydrogels and cultured in DMEM with 10% FBS and 1% PSG for 1 or 2 days. Then, HSC cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments: TGFβ2 (2.5 ng/mL; R&D Systems, Minneapolis, MN, USA; for 3 days), the ROCK inhibitor Y27632 (10 µM; Sigma-Aldrich; for 3 days or 30 minutes only), the actin depolymerizer latrunculin B (10 µM; for 30 minutes only to preserve cell viability; Tocris Bioscience, Bristol, UK; ThermoFisher Scientific), or the YAP inhibitor verteporfin (0.5 µM; Sigma-Aldrich; for 3 days).
+ Open protocol
+ Expand
4

Modulation of HTM Cell Behavior

Check if the same lab product or an alternative is used in the 5 most similar protocols
HTM/GTM cells were seeded at 2 × 104 cells/cm2 on premade hydrogels/coverslips/tissue culture plates, and cultured in DMEM with 10% FBS and 1% PSG for 1 or 2 days. Then, HTM cells were cultured in serum-free DMEM with 1% PSG and subjected to the different treatments for 3 days: TGFβ2 (2.5 ng/ml; R&D Systems, Minneapolis, MN, United States), the ERK inhibitor U0126 (10 μM; Promega, Madison, WI, United States), the Rho-associated kinase (ROCK) inhibitor Y27632 (10 μM; Sigma-Aldrich), the actin de-polymerizer latrunculin B (10 μM; Tocris Bioscience; Thermo Fisher Scientific), or the YAP inhibitor verteporfin (0.5 μM; Sigma). The monolayer HTM cells were processed for immunoblot, qRT-PCR and immunocytochemistry analyses.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!